Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Liver Diseases

Free Subscription Articles published in J Gastroenterol Retrieve available abstracts of 63 articles: HTML format Text format

Single Articles

January 2012
1. KUROKAWA M , Hiramatsu N, Oze T, Yakushijin T, et al
   Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. CHANG CJ , Hou MC, Liao WC, Lee FY, et al
   Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma.
   J Gastroenterol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. GOTO E , Masuzaki R, Tateishi R, Kondo Y, et al
   Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
   J Gastroenterol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. HINO-ARINAGA T , Ide T, Kuromatsu R, Miyajima I, et al
   Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
   J Gastroenterol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. YAMANAKA K , Hatano E, Kitamura K, Iida T, et al
   Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma.
   J Gastroenterol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. REIBERGER T , Ferlitsch A, Payer BA, Pinter M, et al
   Non-selective beta-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
   J Gastroenterol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. KINUGASA H , Nouso K, Takeuchi Y, Yasunaka T, et al
   Erratum to: Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma.
   J Gastroenterol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
8. IGUSA Y , Yamashina S, Izumi K, Inami Y, et al
   Loss of autophagy promotes murine acetaminophen hepatotoxicity.
   J Gastroenterol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. OSAKI Y , Ueda Y, Marusawa H, Nakajima J, et al
   Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study.
   J Gastroenterol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. IWAMOTO T , Terai S, Mizunaga Y, Yamamoto N, et al
    Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KINUGASA H , Nouso K, Takeuchi Y, Yasunaka T, et al
    Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
12. NARAHARA Y , Kanazawa H, Sakamoto C, Maruyama H, et al
    The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. TAKESHITA S , Ichikawa T, Taura N, Miyaaki H, et al
    Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. IMAI Y , Chikayama T, Nakazawa M, Watanabe K, et al
    Usefulness of miriplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
15. HIDAKA H , Nakazawa T, Shibuya A, Minamino T, et al
    Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. NISHIKAWA H , Inuzuka T, Takeda H, Nakajima J, et al
    Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
17. TOKUSHIGE K , Hashimoto E, Horie Y, Taniai M, et al
    Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. SUZUKI H , Murata K, Gotoh T, Kusano M, et al
    Phenotype-dependent production of des-gamma-carboxy prothrombin in hepatocellular carcinoma.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. BEPPU T , Hayashi H, Okabe H, Masuda T, et al
    Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system.
    J Gastroenterol. 2011;46:938-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
20. MURAKAMI K , Takahashi R, Ono M, Watanabe K, et al
    Serodiagnosis of Helicobacter hepaticus infection in patients with liver and gastrointestinal diseases: western blot analysis and ELISA using a highly specific monoclonal antibody for H. hepaticus antigen.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. NG SA , Lee C
    Hepatitis B virus X gene and hepatocarcinogenesis.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. KAWAGUCHI T , Shiba N, Maeda T, Matsugaki T, et al
    Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study.
    J Gastroenterol. 2011;46:746-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. HAMABE A , Uto H, Imamura Y, Kusano K, et al
    Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period.
    J Gastroenterol. 2011;46:769-78.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
24. AIBA Y , Nakamura M, Joshita S, Inamine T, et al
    Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. TOSHIMA T , Shirabe K, Takeishi K, Motomura T, et al
    New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver.
    J Gastroenterol. 2011;46:705-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
26. KOMATSU S , Fukumoto T, Demizu Y, Miyawaki D, et al
    The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
27. HIRAMINE Y , Imamura Y, Uto H, Koriyama C, et al
    Alcohol drinking patterns and the risk of fatty liver in Japanese men.
    J Gastroenterol. 2011;46:519-28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
28. JO M , Nishikawa T, Nakajima T, Okada Y, et al
    Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. NAGAOKI Y , Aikata H, Miyaki D, Murakami E, et al
    Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. FILIK L
    Visceral and subcutaneous fat accumulation and nonalcoholic fatty liver disease.
    J Gastroenterol. 2011;46:418.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
31. TANAKA S , Arii S
    Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. SUGIYAMA H , Onuki K, Ishige K, Baba N, et al
    Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. TAKAHASHI H , Mizuta T, Eguchi Y, Kawaguchi Y, et al
    Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. KOBAYASHI H , Mochizuki H, Morita T, Kotake K, et al
    Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study.
    J Gastroenterol. 2011;46:203-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
35. TANAKA N , Horiuchi A, Yokoyama T, Kaneko G, et al
    Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. PARK H , Okanoue T
    Reply to the letter by M. Yoneda et al. regarding "Ezetimibe therapy in patients with nonalcoholic steatohepatitis"
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
37. BERZIGOTTI A , Rossi V, Tiani C, Pierpaoli L, et al
    Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension.
    J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. EGUCHI Y , Mizuta T, Sumida Y, Ishibashi E, et al
    The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.
    J Gastroenterol. 2011;46 Suppl 1:70-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. HASHIMOTO E , Tokushige K
    Prevalence, gender, ethnic variations, and prognosis of NASH.
    J Gastroenterol. 2011;46 Suppl 1:63-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. PARK H , Shima T, Yamaguchi K, Mitsuyoshi H, et al
    Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.
    J Gastroenterol. 2011;46:101-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
41. YONEDA M , Fujita K, Imajo K, Mawatari H, et al
    Induction of microsomal triglyceride transfer protein expression is a candidate mechanism by which ezetimibe therapy might exert beneficial effects in patients with nonalcoholic steatohepatitis.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
42. KUMADA T , Toyoda H, Kiriyama S, Tanikawa M, et al
    Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. INAMINE T , Nakamura M, Kawauchi A, Shirakawa Y, et al
    A polymorphism in the integrin alphaV subunit gene affects the progression of primary biliary cirrhosis in Japanese patients.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. YAMAMOTO K , Imamura H, Matsuyama Y, Kume Y, et al
    AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.
    J Gastroenterol. 2010;45:1272-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. MIYAGI T , Takehara T, Uemura A, Nishio K, et al
    Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet.
    J Gastroenterol. 2010;45:1247-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
46. MIGITA K , Watanabe Y, Jiuchi Y, Nakamura Y, et al
    Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
47. FU HY , Zhang SR, Wang XH, Saheki T, et al
    The mutation spectrum of the SLC25A13 gene in Chinese infants with intrahepatic cholestasis and aminoacidemia.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
48. SUMIDA Y , Yoneda M, Hyogo H, Yamaguchi K, et al
    A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. CAO G
    Exploring risk factors of hepatitis B virus-associated hepatocellular carcinoma: prospective verse retrospective studies.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
50. YASHIMA Y , Tsujino T, Masuzaki R, Nakai Y, et al
    Increased liver elasticity in patients with biliary obstruction.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
51. LLEO A , Shimoda S, Ishibashi H, Gershwin ME, et al
    Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. YAMASAKI T , Hamabe S, Saeki I, Harima Y, et al
    A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. YOKOMORI H , Oda M, Yoshimura K, Machida S, et al
    Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. TATEYAMA M , Yatsuhashi H, Taura N, Motoyoshi Y, et al
    Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. TSOULFAS G , Kawai T, Elias N, Ko SC, et al
    Long-term experience with liver transplantation for hepatocellular carcinoma.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. KAWAKAMI H , Kuwatani M, Onodera M, Haba S, et al
    Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. HAGIWARA S , Kudo M, Ueshima K, Chung H, et al
    The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon alpha-2b therapy against advanced hepatocellular carcinoma.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. MIYAKE T , Akbar SM, Yoshida O, Chen S, et al
    Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease.
    J Gastroenterol. 2010;45:859-67.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
59. IKUTA Y , Takamori H, Ikeda O, Tanaka H, et al
    Detection of liver metastases secondary to pancreatic cancer: utility of combined helical computed tomography during arterial portography with biphasic computed tomography-assisted hepatic arteriography.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. TASCI I
    Clinical usefulness of AGEs as a biomarker for the attenuation of NASH.
    J Gastroenterol. 2010;45:779-80.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
61. TAKINO J , Kobayashi Y, Takeuchi M
    The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
    J Gastroenterol. 2010;45:646-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. TSURUTA G , Tanaka N, Hongo M, Komatsu M, et al
    Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits.
    J Gastroenterol. 2010;45:666-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
63. KOYABU M , Uchida K, Miyoshi H, Sakaguchi Y, et al
    Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.
    J Gastroenterol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: